The prospects of enhancing cognitive or motor functions using neuroscience in otherwise healthy individuals has attracted considerable attention and interest in neuroethics (Farah et al., Nature Reviews Neuroscience 5:421-425, 2004; Glannon Journal of Medical Ethics 32:74-78, 2006). The use of stimulants is one of the areas which has propelled the discussion on the potential for neuroscience to yield cognition-enhancing products. However, we have found in our review of the literature that the paradigms used to discuss the non-medical use of stimulant drugs prescribed for attention deficit/hyperactivity disorder (ADHD) vary considerably. In this brief communication, we identify three common paradigms-prescription drug abuse, cognitive enhancement, and lifestyle use of pharmaceuticals-and briefly highlight how divergences between paradigms create important "ethics blind spots". © 2008 Springer Science+Business Media B.V.
CITATION STYLE
Racine, E., & Forlini, C. (2010). Cognitive enhancement, lifestyle choice or misuse of prescription drugs? : EEthics blind spots in current debates. Neuroethics. Springer Netherlands. https://doi.org/10.1007/s12152-008-9023-7
Mendeley helps you to discover research relevant for your work.